Tom Wilson discusses better drug manufacturing strategies with Contract Pharma

In pursuit of leaner business models, many of pharma’s leaders and innovators are turning to effective strategic outsourcing strategies to ensure the reliable development and manufacture of active pharmaceutical ingredients (APIs), the most critical component of their drug and therapeutic products. 

Contract Pharma sat down with Tom Wilson, VP, Global Contract Manufacturing Lead at Pfizer CentreOne, to discuss how today’s biopharma companies are turning to their contractors for long-term collaboration and support - covering the necessary elements to create a strategic relationship with a custom API supplier. 

Read the full article here.